weight loss response to semaglutide in postmenopausal women Did you know peri and menopause see a 30% greater when they couple GLP-1’s with HRT? , This powerful combination not only enhances weight loss but also helps manage other Postmenopausal women on the GLP-1
Description
Nakamura J, Kamiya H, Haneda M, et al
Dealing with sugar But lets start with insulin resistance

By keeping track of your weight, food intake, and any side effects, you can stay in control of your treatment
RENAL DISEASE A post-hoc analysis of the SURPASS-4 compared the effect of tirzepatide and glargine insulin on kidney function with a median treatment duration of treatment of 85 weeks (401)

Nausea is reported in 16 to 44 percent of semaglutide users, particularly during dose escalation phases

PlexusDx semaglutide injection and all other GLP-1 treatments are HSA and FSA eligible, allowing you to pay with pre-tax dollars and reduce your true out-of-pocket cost
